1.
To allow us to Buse^their good name and standing in the field of clinical microbiology and infectious diseases to draw attention to the journal and to try and attract good papers in their respective fields of expertise. 2. To ask them to think about possible improvements for the journal, whatever way it comes. 3. If compatible with their busy agendas, to submit (mini) reviews or editorials on topics of their personal interest. 4. To permit us to pick their brains for the possible development of special issues.
To ask them to keep the European Journal of Clinical
Microbiology & Infectious Diseases in mind if they themselves or their close colleagues submit papers for publication.
So, in short: we would like our Advisory Board members to be real ambassadors for the journal! Of course, we will try to organize board meetings, for instance during scientific conferences. However, the past has learned us that communication via e-mail is often more time-efficient. Dr. Willem van Leeuwen will stay on as Mini-review Editor for the years to come and feel free to address him should you have suggestions for topics or if you would have papers immediately available. Over the past years, Willem has managed to attract quite some mini-reviews that were essentially updates of major reviews written by the authors in spe three to four years ago. This gives the authors an opportunity to succinctly summarize the most recent developments in their field and, for us, it generates good papers that are usually extremely timely. Another Beasy^category of mini-reviews to be exploited are the literature summaries that are a standard part of the PhD theses of young investigators. Again, these papers are complete and timely, and publishing such chapters generates additional and free visibility for young authors and their scientific mentors.
A new category of papers?
Scientific and also clinical research as published in scholarly journals is quite often externally funded and major clinical and scientific consortia are constantly developed in order for scientists to be more competitive and visible. Many such consortia get funded and, in general, the proposed work is executed successfully. Given the complexity and size of such consortia, the overall coherence of the work performed is not always clearly visible. We have given this considerable thought and we now offer authors the opportunity to review the outcomes and productivity of such collaborative efforts. In a forthcoming issue, you will see the first example of such a BProject Review^paper. Koulenti and colleagues review the overall achievements of the EU-CAP/VAP project (Koulenti D, Tsigou E, Rello J. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study. Eur J Clin Microbiol Infect Dis. 2016 Jun 10. [Epub ahead of print] Review). We will start soliciting for additional Project Review papers as you read! Summarizing achievements through a Project Review paper enhances the yield of a project, improves its visibility, and, one never knows, may, in the end, contribute to the acquisition of new grants. [12] 10.1007/S10096-012-1766-8 1724 Lambiase et al. 2011 [20] 10.1007/s10096-011-1182-5 40 Wang et al. 2012 [21] 10.1007/s10096-011-1328-5 39
To re-vamp or not?
Journals offer services to a variety of audiences and ours is one of researchers in the field of laboratory science and clinical infectious diseases studies. We do tend not to focus too much on the impact factor of the journal (although our IF did rise from 2.668 for 2014 to 2.857 for 2015) but, rather, provide a forum for publishing practically valuable and clinically actionable research for actors in the field of clinical microbiology and infectious diseases. We are constantly trying to improve quality and attract the best work in this field. This, as you understand, is highly competitive and, for that, we need the support of our Advisory Board and, of course, the support of you, our readers. However, the journal as it is to date has successfully survived for decades and is in good shape. For that, we will, of course, continue evolving the journal, but we will do so at a leisurely pace at most.
Thank you
We thank you, our readers and authors, for your continued support. The European Journal of Clinical Microbiology & Infectious Diseases is a healthy journal which is still wellcirculated in paper format, a feature that many of our readers still seem to enjoy in this increasingly electronic era. Feel free to reach out to me and Willem with specific requests, especially if you would be interested in writing a Project Review manuscript. Tables 1 and 2 as well as Figs. 1 and 2 as included in this editorial give you a small glimpse as to the development of the journal over the past period and, to me, this all looks positive. Looking forward to seeing your best work 
